Clinical trial · Observational
European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma
NCT05763524CI-TRIAL-00064809LACCunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project will evaluate of the number of patients who underwent adrenalectomy for ACC in different European centers using the EUROCRINE® database. The analysis will focus on the extent of lymph nodal dissection (i.e. number of lymph nodes and nodal stations dissected during adrenalectomy). We aim to evaluate the oncologic radicality of surgical treatment and the rate of tumour recurrences after surgery and nodal metastasis related to the stage of the disease and to tumour side (left/right).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adrenocortical Carcinoma | Adrenal Cortical Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Adrenalectomy with or without lymphadenectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Adrenalectomy in patients operated for Adrenocortical Carcinoma
- description
- All adult (18 years old and older) patients registered in EUROCRINE® database that underwent surgery for adrenocortical carcinoma from 2015 till 2021 will be included
- interventionNames
- Procedure: Adrenalectomy with or without lymphadenectomy
Primary outcomes (2)
- measure
- Incidence of Adrenocortical Carcinoma (ACC) among European endocrine centers
- timeFrame
- January 2015- January 2021
- description
- Identification of the number of patients who underwent adrenalectomy for diagnosis of ACC among European centers participating in the Eurocrine database
- measure
- Extent of lymphadenectomy
- timeFrame
- January 2015- January 2021
- description
- Evaluation of the lymph node dissection extension (in terms of number of lymph nodes and nodal stations dissected during surgical treatment for ACC)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: All adult (18 years old and older) patients that underwent surgery with a final histology of adrenocortical carcinoma from 2015 till 2021 Inclusion Criteria: * All adult (18 years old and older) patients * underwent surgery * final histology of adrenocortical carcinoma * among European centers that participate in the Eurocrine® database between 2015 and 2021 Exclusion Criteria: * Patients \<18 years old * Patients with metastatic disease at time of clinical referral
References
Publications (0)
Data not yet available
No reference posted for this study.